These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patients. Lansberg PJ; Mitchel YB; Shapiro D; Kastelein JJ; Altman R; Jerums G; Bolzano K; Giannini S; Davignon J; DeWailly P Atherosclerosis; 1995 Aug; 116(2):153-62. PubMed ID: 7575771 [TBL] [Abstract][Full Text] [Related]
28. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia. O'Brien RC; Simons LA; Clifton P; Cooper ME; Jennings GL; Jerums G; Nestel PJ; Sullivan D Med J Aust; 1990 May; 152(9):480-3. PubMed ID: 2199801 [TBL] [Abstract][Full Text] [Related]
29. Simvastatin in severe primary hypercholesterolemia: efficacy, safety, and tolerability in 595 patients over 18 weeks. The Principal Investigators. Simons LA Clin Cardiol; 1993 Apr; 16(4):317-22. PubMed ID: 8458112 [TBL] [Abstract][Full Text] [Related]
30. [Effects of simvastatin on atherogenic blood lipid pattern]. Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842 [TBL] [Abstract][Full Text] [Related]
31. Short-term safety and efficacy of low-dose simvastatin in elderly patients with hypertensive hypercholesterolemia and fasting hyperinsulinemia. Chan P; Huang TY; Tomlinson B; Lee C; Lee YS J Clin Pharmacol; 1997 Jun; 37(6):496-501. PubMed ID: 9208356 [TBL] [Abstract][Full Text] [Related]
32. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. Darling GM; Johns JA; McCloud PI; Davis SR N Engl J Med; 1997 Aug; 337(9):595-601. PubMed ID: 9271481 [TBL] [Abstract][Full Text] [Related]
34. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin. Nestel P; Simons L; Barter P; Clifton P; Colquhoun D; Hamilton-Craig I; Sikaris K; Sullivan D Atherosclerosis; 1997 Mar; 129(2):231-9. PubMed ID: 9105566 [TBL] [Abstract][Full Text] [Related]
35. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia. Farnier M; Bonnefous F; Debbas N; Irvine A Arch Intern Med; 1994 Feb; 154(4):441-9. PubMed ID: 8117177 [TBL] [Abstract][Full Text] [Related]
37. Hypercholesterolemia in non-insulin-dependent diabetes mellitus: different effect of simvastatin on VLDL and LDL cholesterol levels. Cassader M; Ruiu G; Gambino R; Alemanno N; Veglia F; Pagano G Atherosclerosis; 1993 Feb; 99(1):47-53. PubMed ID: 8461059 [TBL] [Abstract][Full Text] [Related]
38. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels. Kroon AA; van't Hof MA; Demacker PN; Stalenhoef AF Atherosclerosis; 2000 Oct; 152(2):519-26. PubMed ID: 10998482 [TBL] [Abstract][Full Text] [Related]
39. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Hsu I; Spinler SA; Johnson NE Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093 [TBL] [Abstract][Full Text] [Related]
40. [The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus]. van Deursen RT; Nieuwenhuijzen Kruseman AC; Degenaar CP; Wolffenbuttel BH Ned Tijdschr Geneeskd; 1990 Nov; 134(44):2142-6. PubMed ID: 2247172 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]